Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Lumos Pharma, Inc. Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 May 20, 2024 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results May 14, 2024 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024 May 09, 2024 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings April 18, 2024 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 March 20, 2024 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update March 07, 2024 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024 February 26, 2024 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference February 05, 2024 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer January 04, 2024 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency November 21, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November November 20, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates November 07, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints November 07, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting September 26, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announced Abstract Accepted for Oral Presentation at the European Society for Paediatric Endocrinology Annual Meeting September 14, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announces Participation in Investor Conferences in September September 07, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape August 22, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update August 09, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Report Second Quarter 2023 Financial Results and Host Conference Call on August 9, 2023 July 26, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences Summit July 12, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announces Departure of Chief Medical Officer June 28, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos to Highlight New LUM-201 Data and Analysis Presented at ENDO 2023 in Virtual KOL Webinar June 21, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Participate in the Upcoming 2023 BIO International Convention and the Jefferies Healthcare Conference May 31, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Announces Abstracts Accepted for Oral Presentation at 2023 ENDO Meeting with Virtual KOL Event to be Held on June 21st May 25, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Participate in World Orphan Drug Congress USA May 22, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Encouraging Data from Lumos Pharma OraGrowtH Trials Presented at Annual Pediatric Endocrine Society Meeting (PES) May 08, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical Updates May 03, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Data from Lumos Pharma OraGrowtH Trials to be Presented at Annual Pediatric Endocrine Society Meeting (PES) April 27, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Report First Quarter 2023 Financial Results and Host Conference Call on May 3, 2023 April 19, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Lumos Pharma to Participate in Oppenheimer’s 33rd Annual Healthcare Conference Held Virtually March 13-15, 2023 March 09, 2023 From Lumos Pharma, Inc. Via GlobeNewswire Tickers LUMO Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.